Genovis AB (FRA:5GV) Cyclically Adjusted PB Ratio: (As of Sep. 21, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:5GV Genovis AB FRA:5GV
94 GF Score
Price €1.74
GF Value €2.32
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Genovis AB Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Genovis AB  (FRA:5GV) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Genovis AB Cyclically Adjusted PB Ratio Related Terms


Genovis AB Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for Genovis AB's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Genovis AB Cyclically Adjusted PB Ratio Chart

Genovis AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 85.71 40.30 43.99 15.45 11.25

Genovis AB Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.22 13.39 11.89 8.72 9.39

FRA:5GV vs VRTX, REGN, MRNA: Cyclically Adjusted PB Ratio Comparison

For the Biotechnology subindustry, Genovis AB's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Genovis AB Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Genovis AB's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Genovis AB's Cyclically Adjusted PB Ratio falls into.


FRA:5GV
94GF Score
Genovis AB FRA:5GV
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Genovis AB Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Genovis AB's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, Genovis AB's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book=Book Value per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0.413/134.6100*134.6100
=0.413

Current CPI (Jun. 2026) = 134.6100.

Genovis AB Quarterly Data

Book Value per Share CPI Adj_Book
201609 0.034 101.138 0.045
201612 0.029 102.022 0.038
201703 0.024 102.022 0.032
201706 0.036 102.752 0.047
201709 0.033 103.279 0.043
201712 0.031 103.793 0.040
201803 0.027 103.962 0.035
201806 0.037 104.875 0.047
201809 0.038 105.679 0.048
201812 0.041 105.912 0.052
201903 0.042 105.886 0.053
201906 0.044 106.742 0.055
201909 0.054 107.214 0.068
201912 0.054 107.766 0.067
202003 0.117 106.563 0.148
202006 0.117 107.498 0.147
202009 0.118 107.635 0.148
202012 0.133 108.296 0.165
202103 0.132 108.360 0.164
202106 0.135 108.928 0.167
202109 0.137 110.338 0.167
202112 0.169 112.486 0.202
202203 0.187 114.825 0.219
202206 0.182 118.384 0.207
202209 0.187 122.296 0.206
202212 0.173 126.365 0.184
202303 0.230 127.042 0.244
202306 0.242 129.407 0.252
202309 0.253 130.224 0.262
202312 0.262 131.912 0.267
202403 0.271 132.205 0.276
202406 0.279 132.716 0.283
202409 0.300 132.304 0.305
202412 0.304 132.987 0.308
202503 0.327 132.825 0.331
202506 0.326 133.699 0.328
202509 0.361 133.480 0.364
202512 0.380 133.380 0.384
202603 0.383 133.550 0.386
202606 0.413 134.610 0.413

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Genovis AB (FRA:5GV) Overvalued in 2026?

Based on GuruFocus' analysis, Genovis AB stock appears to be undervalued. The current stock price of €1.74 is trading 25% below its estimated GF Value™ of €2.32. GuruFocus considers Genovis AB to be Modestly Undervalued.

Key valuation signals for FRA:5GV:

  • Cyclically Adjusted PB Ratio:
  • GF Value™: €2.32 vs. price of €1.74 (25% below fair value)
  • GF Score™: 94/100 with 4 warning signs

No single metric tells the full story. See the FRA:5GV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Genovis AB Business Description

Other Exchanges GENO:Sweden
Address Kavlinge, Box 4, Lund, SWE, SE-24421
Genovis AB offers customers in the biopharmaceutical and research industries tools that facilitate and save time in the development of new treatment methods and diagnostics. Its enzyme products, known as SmartEnzymes, are used by scientists all over the world, and the product formats facilitate the development and quality control of biological drugs. Its products include Enzyme and Antibodies. Geographically, it operates in Sweden and Rest of the world.
94GF Score

Get the complete analysis for FRA:5GV

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.74
Price
€2.32
GF Value